Orphan Medical
An orphan drug is a pharmaceutical agent developed to treat medical conditions which, because they are so rare, would not be profitable to produce without government assistance. The conditions are referred to as orphan diseases.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Alprolix | Eftrenonacog alfa | 2016-05-12 | ||
| Aspaveli | Pegcetacoplan | 2021-12-13 | 2026-2038 | |
| Doptelet | Avatrombopag | 2019-06-20 | 2027 | |
| Elocta | Efmoroctocog alfa | 2015-11-18 | ||
| Gamifant | Emapalumab | 2018-11-20 | ||
| Kepivance | Palifermin | 2004-12-15 | ||
| Kineret | Anakinra | 2001-11-14 | ||
| Orfadin | Nitisinone | 2002-01-18 | 2033-2035 | |
| Synagis | Palivizumab | 1998-06-19 | ||
| Xiapex | Collagenase clostridium histolyticum | 2011-02-28 | — | |
| Zynlonta | Loncastuximab tesirine | 2022-12-20 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use